Miral, Genilyn C.
HRN: 28-13-26 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
CEFTAZIDIME 1GM (VIAL)
12/30/2025
01/06/2026
IV
2g
Q8h
CAP MR
Checking Initial Appropriateness
12/30/2025
AZITHROMYCIN 500MG TABLET (TAB)
12/30/2025
01/04/2026
PO
500mg
OD
CAP MR
Checking Final Appropriateness